Cargando…
Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
Background: The mechanism of tumorigenicity potentially evolved in mesenchymal stem cells (MSCs) remains elusive, resulting in inconsistent clinical application efficacy. We hypothesized that subclones in MSCs contribute to their tumorgenicity, and we approached MSC-subclones at the single-cell leve...
Autores principales: | Stucky, Andres, Gao, Li, Li, Shengwen Calvin, Tu, Lingli, Luo, Jun, Huang, Xi, Chen, Xuelian, Li, Xiaoqing, Park, Tiffany H., Cai, Jin, Kabeer, Mustafa H., Plant, Ashley S., Sun, Lan, Zhang, Xi, Zhong, Jiang F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959432/ https://www.ncbi.nlm.nih.gov/pubmed/35356283 http://dx.doi.org/10.3389/fcell.2022.699144 |
Ejemplares similares
-
Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel
por: Li, Shengwen Calvin, et al.
Publicado: (2018) -
RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression
Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for
Pediatric Neuroblastoma
por: Sun, Lan, et al.
Publicado: (2023) -
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
por: Li, Xiaoqing, et al.
Publicado: (2021) -
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
por: Li, Xiaoqing, et al.
Publicado: (2022) -
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
por: Zeng, Yunjing, et al.
Publicado: (2018)